Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

Press releases published on August 6, 2026

4 hours ago

SRX Global to Host Fiscal Third Quarter 2026 Conference Call on August 13 at 4:30 p.m. ET

Indeterminate GlobeNewswire

4 hours ago

Easy Environmental Solutions Is Saving 1000’s Of Trees From Disease & Forced Removal

Indeterminate GlobeNewswire

4 hours ago

Trimedx unveils new brand aligned to its expanding presence and market position

Indeterminate GlobeNewswire

4 hours ago

Vistagen Announces Topline Results for Repeat Dose Study of Fasedienol for Acute Treatment of Social Anxiety Disorder

Indeterminate GlobeNewswire

4 hours ago

RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors

Indeterminate GlobeNewswire

4 hours ago

Propanc Biopharma Announces Positive Preclinical and Early Translational Data for PRP Showing >90% Tumor Growth Inhibition and Significant Survival Benefit in Pancreatic Ductal Adenocarcinoma Models

Indeterminate GlobeNewswire

4 hours ago

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Indeterminate GlobeNewswire

4 hours ago

iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants

Indeterminate GlobeNewswire

4 hours ago

MiNK Therapeutics to Report Second Quarter 2026 Financial Results, Provide Clinical Updates on agenT-797 in Lung Injury, and Highlight Important Business Updates

Indeterminate GlobeNewswire

4 hours ago

CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire

4 hours ago

VivoSim Provides Financial and Listing Compliance Update

Indeterminate GlobeNewswire

4 hours ago

Harmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium

Indeterminate GlobeNewswire

4 hours ago

Medecision Earns “Innovators” Distinction in Frost & Sullivan’s 2026 Frost Radar™ Report

Indeterminate GlobeNewswire

5 hours ago

Theriva™ Biologics Announces First Patient Dosed in VIRAGE2 Phase 2a Clinical Trial to Evaluate More Frequent Dosing of VCN-01 (zabilugene almadenorepvec) in First-Line Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Indeterminate GlobeNewswire

5 hours ago

Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference

Indeterminate GlobeNewswire

5 hours ago

Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases

Indeterminate GlobeNewswire

5 hours ago

vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

5 hours ago

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

5 hours ago

LENSAR® to Report Second Quarter 2026 Results on August 13th, 2026

Indeterminate GlobeNewswire

5 hours ago

Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire